Schomberg D W, Couse J F, Mukherjee A, Lubahn D B, Sar M, Mayo K E, Korach K S
Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Endocrinology. 1999 Jun;140(6):2733-44. doi: 10.1210/endo.140.6.6823.
Targeted disruption of the mouse estrogen receptor-alpha gene (estrogen receptor-alpha knockout; ERKO) results in a highly novel ovarian phenotype in the adult. The ERKO mouse model was used to characterize ER alpha-dependent processes in the ovary. Visualization of the ovaries of 10-, 20-, and 50-day-old wild-type (WT) and ERKO mice showed that the ERKO phenotype developed between 20 and 50 days of age. Developmental progression through the primordial, primary, and antral follicle stages appeared normal, but functional maturation of preovulatory follicles was arrested resulting in atresia or in anovulatory follicles, which in many cases formed large, hemorrhagic cysts. Corpora lutea were absent, which also indicates that the normal biochemical and mechanical processes that accomplish ovulation were compromised. Northern and ribonuclease protection analyses indicated that ERKO ovary FSH receptor (FSHR) messenger RNA (mRNA) expression was approximately 4-fold greater than in WT controls. Ovarian LH receptor (LHR) mRNA expression was also higher in the ERKO animals. Cellular localization studies by in situ hybridization analysis of ERKO ovaries showed a high level of LHR mRNA expression in the granulosa and thecal layers of virtually all the antral follicles. Ribonuclease protection analyses showed that ovarian progesterone receptor and androgen receptor mRNA expression were similar in the two groups. These results indicated that ER alpha action was not a prerequisite for LHR mRNA expression by thecal or granulosa cells or for ovarian expression of progesterone receptor mRNA. Ovarian estrogen receptor beta (ER beta) was detected immunohistochemically, was sharply compartmentalized to the granulosa cells, and was expressed approximately equally in the ERKO animals and the WT controls. In contrast, ER alpha staining was present in the thecal cells but not the granulosa cells of the WT animals. The summary findings indicate that in the adult the major cause of the ERKO phenotype is high circulating LH interacting with functional LHR of the theca and granulosa cells. These features result in a failure of the normal maturational events leading to successful ovulation and luteinization and presumably involve both hypothalamic-pituitary and intraovarian mechanisms dependent upon ER alpha action. The presence of ER beta in the granulosa cells did not rescue the phenotype of the ovary.
对小鼠雌激素受体α基因进行靶向破坏(雌激素受体α基因敲除;ERKO)会在成年小鼠中导致一种非常新颖的卵巢表型。ERKO小鼠模型被用于表征卵巢中雌激素受体α依赖性过程。对10日龄、20日龄和50日龄野生型(WT)及ERKO小鼠的卵巢进行可视化观察发现,ERKO表型在20至50日龄之间形成。卵泡从原始卵泡、初级卵泡到窦状卵泡阶段的发育进程看似正常,但排卵前卵泡的功能成熟被阻断,导致闭锁或形成无排卵卵泡,在许多情况下这些卵泡会形成大的出血性囊肿。黄体缺失,这也表明完成排卵的正常生化和机械过程受到了损害。Northern印迹分析和核糖核酸酶保护分析表明,ERKO小鼠卵巢中促卵泡激素受体(FSHR)信使核糖核酸(mRNA)的表达比野生型对照高约4倍。ERKO小鼠卵巢中促黄体生成素受体(LHR)mRNA的表达也更高。通过对ERKO小鼠卵巢进行原位杂交分析的细胞定位研究表明,几乎所有窦状卵泡的颗粒层和卵泡膜层中LHR mRNA表达水平都很高。核糖核酸酶保护分析表明,两组中卵巢孕酮受体和雄激素受体mRNA的表达相似。这些结果表明,雌激素受体α的作用并非卵泡膜细胞或颗粒细胞表达LHR mRNA以及卵巢表达孕酮受体mRNA的必要条件。通过免疫组织化学方法检测到卵巢雌激素受体β(ERβ),其在颗粒细胞中呈明显的区域化分布,并且在ERKO小鼠和野生型对照中的表达大致相等。相比之下,野生型动物的卵泡膜细胞中有雌激素受体α染色,而颗粒细胞中没有。总结这些发现表明,在成年小鼠中,ERKO表型的主要原因是循环中高水平的促黄体生成素与卵泡膜细胞和颗粒细胞的功能性促黄体生成素受体相互作用。这些特征导致正常成熟事件失败,无法成功排卵和黄体化,推测这涉及下丘脑 - 垂体以及依赖雌激素受体α作用的卵巢内机制。颗粒细胞中雌激素受体β的存在并不能挽救卵巢的表型。